159 related articles for article (PubMed ID: 2624994)
21. [Primary hyperoxaluria].
Cochat P; Fargue S; Bacchetta J; Bertholet-Thomas A; Sabot JF; Harambat J
Nephrol Ther; 2011 Jul; 7(4):249-59. PubMed ID: 21636340
[TBL] [Abstract][Full Text] [Related]
22. Pyridoxamine lowers kidney crystals in experimental hyperoxaluria: a potential therapy for primary hyperoxaluria.
Chetyrkin SV; Kim D; Belmont JM; Scheinman JI; Hudson BG; Voziyan PA
Kidney Int; 2005 Jan; 67(1):53-60. PubMed ID: 15610227
[TBL] [Abstract][Full Text] [Related]
23. Prenatal exclusion of primary hyperoxaluria type 1.
Danpure CJ; Jennings PR; Penketh RJ; Wise PJ; Rodeck CH
Lancet; 1988 Feb; 1(8581):367. PubMed ID: 2893183
[No Abstract] [Full Text] [Related]
24. The appearance of oxalate crystals in a kidney biopsy is no proof of post-transplant oxalate nephropathy in primary hyperoxaluria type 1.
Metry EL; Oosterveld MJS; Groothoff JW; Bacchetta J
Kidney Int; 2022 Aug; 102(2):446. PubMed ID: 35870818
[No Abstract] [Full Text] [Related]
25. [13C2]oxalate absorption in children with idiopathic calcium oxalate urolithiasis or primary hyperoxaluria.
Sikora P; von Unruh GE; Beck B; Feldkötter M; Zajaczkowska M; Hesse A; Hoppe B
Kidney Int; 2008 May; 73(10):1181-6. PubMed ID: 18337715
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of a high-performance liquid chromatography method for urinary oxalate determination and investigation regarding the pediatric reference interval of spot urinary oxalate to creatinine ratio for screening of primary hyperoxaluria.
Shen Y; Luo X; Li H; Guan Q; Cheng L
J Clin Lab Anal; 2021 Aug; 35(8):e23870. PubMed ID: 34097312
[TBL] [Abstract][Full Text] [Related]
27. Oxalate metabolism in renal stone disease with special reference to calcium metabolism and intestinal absorption.
Lindsjö M
Scand J Urol Nephrol Suppl; 1989; 119():1-53. PubMed ID: 2669121
[TBL] [Abstract][Full Text] [Related]
28. Primary Hyperoxaluria Screening and Monitoring: Quantitative Measurement of Plasma Oxalate by Gas Chromatography-Mass Spectrometry With High Sensitivity.
Yazdanpanah M; Cameron J; Chappel C; Yuan L
Ann Lab Med; 2024 May; 44(3):235-244. PubMed ID: 37904578
[TBL] [Abstract][Full Text] [Related]
29. Hyperoxaluria, hyperglycoluria and renal oxalosis in Gilbert's potoroos (Potorous gilbertii).
Forshaw D; Horwitz AM; Ellard K; Friend JA; Greed L; Metz M
Aust Vet J; 2017 Jul; 95(7):250-258. PubMed ID: 28653383
[TBL] [Abstract][Full Text] [Related]
30. Primary Hyperoxaluria Type 3 Can Also Result in Kidney Failure: A Case Report.
Singh P; Granberg CF; Harris PC; Lieske JC; Licht JH; Weiss A; Milliner DS
Am J Kidney Dis; 2022 Jan; 79(1):125-128. PubMed ID: 34245816
[TBL] [Abstract][Full Text] [Related]
31. Predictors of Incident ESRD among Patients with Primary Hyperoxaluria Presenting Prior to Kidney Failure.
Zhao F; Bergstralh EJ; Mehta RA; Vaughan LE; Olson JB; Seide BM; Meek AM; Cogal AG; Lieske JC; Milliner DS;
Clin J Am Soc Nephrol; 2016 Jan; 11(1):119-26. PubMed ID: 26656319
[TBL] [Abstract][Full Text] [Related]
32. Potential mechanisms of marked hyperoxaluria not due to primary hyperoxaluria I or II.
Monico CG; Persson M; Ford GC; Rumsby G; Milliner DS
Kidney Int; 2002 Aug; 62(2):392-400. PubMed ID: 12110000
[TBL] [Abstract][Full Text] [Related]
33. Clinical features of genetically confirmed patients with primary hyperoxaluria identified by clinical indication versus familial screening.
Sas DJ; Enders FT; Mehta RA; Tang X; Zhao F; Seide BM; Milliner DS; Lieske JC
Kidney Int; 2020 Apr; 97(4):786-792. PubMed ID: 32093915
[TBL] [Abstract][Full Text] [Related]
34. Postprandial hyperoxaluria and intestinal oxalate absorption in idiopathic renal stone disease.
Schwille PO; Hanisch E; Scholz D
J Urol; 1984 Oct; 132(4):650-5. PubMed ID: 6471206
[TBL] [Abstract][Full Text] [Related]
35. Regressive course of oxalate deposition in primary hyperoxaluria after kidney transplantation.
Celik G; Sen S; Sipahi S; Akkin C; Tamsel S; Töz H; Hoscoskun C
Ren Fail; 2010; 32(9):1131-6. PubMed ID: 20863224
[TBL] [Abstract][Full Text] [Related]
36. [Effect of stiripentol on urine oxalate excretion].
Letavernier E; Daudon M
Nephrol Ther; 2021 Apr; 17S():S95-S99. PubMed ID: 33910706
[TBL] [Abstract][Full Text] [Related]
37. The hyperoxaluric syndromes.
Wandzilak TR; Williams HE
Endocrinol Metab Clin North Am; 1990 Dec; 19(4):851-67. PubMed ID: 2081515
[TBL] [Abstract][Full Text] [Related]
38. Dietary risk factors for hyperoxaluria in calcium oxalate stone formers.
Siener R; Ebert D; Nicolay C; Hesse A
Kidney Int; 2003 Mar; 63(3):1037-43. PubMed ID: 12631085
[TBL] [Abstract][Full Text] [Related]
39. Oxalobacter formigenes colonization normalizes oxalate excretion in a gastric bypass model of hyperoxaluria.
Canales BK; Hatch M
Surg Obes Relat Dis; 2017 Jul; 13(7):1152-1157. PubMed ID: 28552742
[TBL] [Abstract][Full Text] [Related]
40. Efficacy and safety of Oxalobacter formigenes to reduce urinary oxalate in primary hyperoxaluria.
Hoppe B; Groothoff JW; Hulton SA; Cochat P; Niaudet P; Kemper MJ; Deschênes G; Unwin R; Milliner D
Nephrol Dial Transplant; 2011 Nov; 26(11):3609-15. PubMed ID: 21460356
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
